 |
| Global Endobronchial Ultrasound Biopsy Market Size |
Endobronchial ultrasound biopsy (EBUS-TBNA) is a minimally invasive procedure
used to diagnose mediastinal and hilar lymphadenopathy. EBUS biopsy provides
distinct advantages over conventional tissue sampling methods, such as superior
visualization of lesions and real-time guidance to access small lesions closer
to the trachea and major bronchi.
The global
Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected
to exhibit a CAGR of 7.4% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increasing adoption of minimally invasive biopsy procedures is expected to
aid the growth of the endobronchial ultrasound biopsy market over the forecast
period. Minimally invasive procedures are associated with benefits such as
reduced postoperative complications, smaller incisions, shorter hospital stay,
and quicker recovery in comparison to traditional open surgeries. EBUS biopsy
is a minimally invasive procedure that has proven to be highly accurate for
staging and sampling of lung cancer. Moreover, EBUS biopsy minimizes trauma to
adjacent structures and helps in quicker diagnosis. Growing public awareness
about benefits of minimally invasive procedures over conventional open
surgeries is expected to drive the adoption of endobronchial ultrasound biopsy.
Segment
Analysis
The global endobronchial ultrasound biopsy market is dominated by endobronchial
biopsy needles sub segment due to growing demand for minimally invasive
procedures for lung biopsy sampling. Endobronchial biopsy needles account for
over 45% of the total market share owing to various advantages such as real
time imaging, easy navigation and sampling of lesions beyond visible airways.
Key Takeaways
Global
Endobronchial Ultrasound Biopsy Market Size is expected to witness high
growth during the forecast period of 2023 to 2030. The market is projected to
reach a value of US$ 722.67 Bn by
2024 growing at a CAGR of 7.4% through
2030.
Regional analysis: Asia Pacific region is expected to be the fastest growing
regional market for endobronchial ultrasound biopsy growing at around 9% CAGR
owing to rising healthcare expenditure, increasing lung cancer incidence and
growing medical tourism in countries like India and China. North America currently
dominates the market with over 35% share led by robust healthcare
infrastructure and availability of advanced diagnostic procedures in the US and
Canada.
Key players
operating in the endobronchial ultrasound biopsy market are Alf Engineering, F
TECH, Magna International, Metalsa, Nissin Kogyo, Sango Co., Ltd., Tata
Precision Tubes, Tenneco, Thyssenkrupp AG, Vari-Form, and Yorozu. The market is
consolidated in nature with top 5 players accounting for over 55% share.
Players are focused on new product launches and geographic expansion strategies
to gain competitive edge.
Get More Insights On This Topic: https://www.ukwebwire.com/global-endobronchial-ultrasound-biopsy-market-share/